Connect with us

Hi, what are you looking for?

Economy

Russia’s Sputnik V vaccine gets emergency use approval; available AstraZeneca doses allocated to medical workers

PHILIPPINE authorities have approved Russias Sputnik V coronavirus vaccine, the fourth to be allowed for emergency use in the country.   

The potential benefits of the vaccine developed by the Gamaleya Institute in Moscow outweighits potential risks as seen in a late-stage trial, making it qualified for urgent use in the country, Food and Drug Administration Director General Rolando Enrique D. Domingo said at a virtual press briefing on Friday.

“The known and potential benefits of the Gamaleya Sputnik V vaccine, when used to prevent COVID-19 (coronavirus disease 2019), outweigh the known and potential risks of said vaccine as of date,” Mr. Domingo said.

The Russian Direct Investment Fund (RDIF), in a statement on Friday, said the Philippines was among the first to show interest in the Sputnik vaccine after it was registered in Russia.

The two-shot vaccine, which has a 91.6% efficacy, provides full protection against severe coronavirus cases as confirmed by a medical journal published by a Netherland-based publication, RDIF said.

Sputnik V, which can be stored in a conventional refrigerator, costs less than $10 per shot, it said.

Diversification of the national vaccine portfolio through registration of Sputnik V provides people of the Philippines with access to one of the best vaccines, which is already saving lives around the world.

With its emergency use authorization (EUA) in the country, the Russian shot might arrive in Manila as soon as April, Secretary Carlito G. Galvez, who heads the countrys COVID-19 vaccine program, told a virtual press briefing on Friday.

Mr. Galvez earlier said the Philippines is eyeing to purchase five to ten million doses of Sputnik V. 

ASTRAZENECA

Also on Friday, President Rodrigo R. Duterte approved the recommendation of the Health department to use all on-hand vaccines obtained from a global initiative for equal access as first doses for medical workers.

The available vaccines developed by British drugmaker AstraZeneca, Plc will be distributed among healthcare workers in areas facing a renewed surge in coronavirus infections, Presidential Spokesman Herminio L. Roque, Jr. said, quoting Executive Secretary Salvadaor C. Medialdea.

The Palace has yet to release a copy of the memorandum.

Nakikita namin na may valid reason po yun na magconcentrate muna tayo sa mga (We recognize that there is a valid reason for concentrating the vaccination for now in the) affected areas,Mr. Galvez said.

The Health department made the recommendation to use all available AstraZeneca doses as a first shot for medical frontliners to ensure that no supply would go to waste.

The Philippines on March 4 took delivery of about 487,200 AstraZeneca doses. An additional 48,300 AstraZeneca vaccines arrived in the country three days later. Kyle Aristophere T. Atienza

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

EasyJet plunged £213 million into the red in the Christmas quarter and is still burning through £150 million in cash each month, putting its...

Investing

A new range of healthy yet indulgent cookies will launch in Booths this month for just £1 per pack with the UK-born snacks by...

Investing

Payments firm Checkout.com has raised $1bn (£730m), giving it a $40bn (£29bn) valuation and crowning it the UK’s most valuable private fintech. The London-headquartered...

Investing

Sylvera, a UK-based startup that provides ratings for carbon offsets, has raised $32.6m (£24.1m) in a Series A funding round to accelerate and expand...

Investing

UK-based fintech Everything has raised €2m (£1.67m) to reinvent a decades-old financial product: premium bonds. The raise was led by a group of angel...

Investing

Boxt, a UK smart home heating startup that provides an “Uber-style” service for fitting boilers, electric vehicle chargers and air conditioning, has raised £20m...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.